- Home
- NVAX vs WULF Comparison
NVAX vs WULF Comparison
Compare NVAX & WULF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVAX
- WULF
- Stock Information
- Founded
- NVAX 1987
- WULF 1952
- Country
- NVAX United States
- WULF United States
- Employees
- NVAX N/A
- WULF N/A
- Industry
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- WULF EDP Services
- Sector
- NVAX Health Care
- WULF Technology
- Exchange
- NVAX Nasdaq
- WULF Nasdaq
- Market Cap
- NVAX 1.3B
- WULF 1.5B
- IPO Year
- NVAX 1995
- WULF 1995
- Fundamental
- Price
- NVAX $7.34
- WULF $3.53
- Analyst Decision
- NVAX Buy
- WULF Strong Buy
- Analyst Count
- NVAX 5
- WULF 10
- Target Price
- NVAX $19.00
- WULF $7.90
- AVG Volume (30 Days)
- NVAX 14.2M
- WULF 39.8M
- Earning Date
- NVAX 05-08-2025
- WULF 05-09-2025
- Dividend Yield
- NVAX N/A
- WULF N/A
- EPS Growth
- NVAX N/A
- WULF N/A
- EPS
- NVAX 2.97
- WULF N/A
- Revenue
- NVAX $1,254,962,000.00
- WULF $132,023,000.00
- Revenue This Year
- NVAX $40.01
- WULF $53.17
- Revenue Next Year
- NVAX N/A
- WULF $91.67
- P/E Ratio
- NVAX $2.47
- WULF N/A
- Revenue Growth
- NVAX 25.92
- WULF 31.85
- 52 Week Low
- NVAX $5.01
- WULF $2.04
- 52 Week High
- NVAX $23.86
- WULF $9.30
- Technical
- Relative Strength Index (RSI)
- NVAX 55.86
- WULF 50.73
- Support Level
- NVAX $6.84
- WULF $3.73
- Resistance Level
- NVAX $7.62
- WULF $4.09
- Average True Range (ATR)
- NVAX 0.55
- WULF 0.31
- MACD
- NVAX 0.07
- WULF -0.03
- Stochastic Oscillator
- NVAX 50.52
- WULF 39.64
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
About WULF TeraWulf Inc.
TeraWulf Inc is a digital asset technology company that is engaged in digital infrastructure and sustainable energy development. It is involved in supporting environmentally conscious bitcoin mining operations by developing and operating facilities within the United States. The company's bitcoin mining facilities are powered by clean, affordable, and reliable energy sources. Its primary source of revenue stems from the mining of bitcoin conducted at the company's mining facility sites. Additionally, the company occasionally generates revenue through the provision of miner hosting services to third-party entities.